By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OxThera, Inc. 

13709 Progress Boulevard, Box 17

Alachua  Florida  32615  U.S.A.
Phone: 386-418-1428 Fax: 386-418-1583


Company News
Matthew Gantz Appointed CEO Of OxThera, Inc. 7/5/2017 9:33:21 AM
OxThera, Inc. Raises EUR 32 Million To Complete Development Of Oxabact For Treatment Of Primary Hyperoxaluria 11/29/2016 9:45:26 AM
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014 9:07:52 AM
OxThera, Inc. Receives SEK 70 Million Financing To Continue Its Key Clinical Programs 4/16/2014 6:23:48 AM
OxThera, Inc. Coordinates FP7 Project, Elimox - €2.19 Million Provided for Drug Development in Hyperoxaluria 9/24/2013 9:46:14 AM
OxThera, Inc. Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria 6/4/2013 9:08:42 AM
OxThera, Inc. Resumes Clinical Development of Hyperoxaluria Therapy 6/7/2012 10:48:03 AM
OxThera, Inc.: Pivotal Study is Being Conducted with Oxabact(TM) for the Treatment of Primary Hyperoxaluria 4/3/2008 9:20:54 AM